Teladoc Health logo

Teladoc Health (TDOC) Q2 2024 Earnings

TDOC·Reported July 31, 2024·After market close

Teladoc Health reported Q2 2024 revenue of $642.4M, missed analyst consensus of $649.7M by $7.2M. Diluted EPS came in at $-0.28, beat the $-0.36 consensus by $0.08.

Revenue
$642.4Mmissed by $7.2M
Consensus: $649.7M
Diluted EPS
$-0.28beat by $0.08
Consensus: $-0.36
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Teladoc Health's Q2 2024 earnings report.

Teladoc Health (TDOC) reported Q2 2024 earnings on July 31, 2024 after market close.

Teladoc Health reported revenue of $642.4M and diluted EPS of $-0.28 for Q2 2024.

Revenue missed the consensus estimate of $649.7M by $7.2M. EPS beat the consensus estimate of $-0.36 by $0.08.

You can read the 10-Q periodic report (0001477449-24-000174) directly on SEC EDGAR. The filing index links above go to sec.gov.